LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 87.14 | 771.67 | 5020 | 12592 | 0.3987 | 0.5918 | MN20160304_L01 | N06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 87.14 | 771.67 | 5386 | 12592 | 0.4277 | 0.6198 | MN20160304_L01 | N20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 2.49 | 771.67 | 920 | 867 | 1.0602 | 1.8250 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 2.49 | 771.67 | 975 | 867 | 1.1236 | 2.9808 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 4.71 | 771.67 | 984 | 956 | 1.0289 | 1.1927 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 4.71 | 771.67 | 1023 | 956 | 1.0697 | 1.4860 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 6.94 | 771.67 | 1031 | 1045 | 0.9865 | 0.9388 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 6.94 | 771.67 | 1114 | 1045 | 1.0659 | 1.3140 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 9.16 | 771.67 | 1079 | 1138 | 0.9477 | 0.8175 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 9.16 | 771.67 | 1197 | 1138 | 1.0514 | 1.1868 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 11.56 | 771.67 | 1158 | 1280 | 0.9043 | 0.7427 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 11.56 | 771.67 | 1204 | 1280 | 0.9402 | 0.8381 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 13.78 | 771.67 | 1196 | 1459 | 0.8193 | 0.6104 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 13.78 | 771.67 | 1301 | 1459 | 0.8913 | 0.7647 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 16.00 | 771.67 | 1241 | 1585 | 0.7827 | 0.5799 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 16.00 | 771.67 | 1383 | 1585 | 0.8723 | 0.7535 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 18.22 | 771.67 | 1269 | 1741 | 0.7287 | 0.5275 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 18.22 | 771.67 | 1431 | 1741 | 0.8218 | 0.6921 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 20.44 | 771.67 | 1274 | 1910 | 0.6667 | 0.4671 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 20.44 | 771.67 | 1388 | 1910 | 0.7264 | 0.5664 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 22.66 | 771.67 | 1213 | 2141 | 0.5664 | 0.3595 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 22.66 | 771.67 | 1403 | 2141 | 0.6552 | 0.5008 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.89 | 771.67 | 1201 | 2397 | 0.5009 | 0.3106 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.89 | 771.67 | 1341 | 2397 | 0.5593 | 0.4020 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 27.11 | 771.67 | 1206 | 2675 | 0.4508 | 0.2827 | MN20160304_L01 | H15 |